Mustang Bio, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2024


	For the year ended December 31,
	2024		2023
Statutory federal income tax rate	21	%	21	%
State taxes, net of federal tax benefit	16	%	16	%
Non-deductible items	(1)	%	—	%
Tax credits	1	%	4	%
Other	(10)	%	(3)	%
Change in valuation allowance	(27)	%	(38)	%
Income taxes provision (benefit)	—		—


	For the year ended December 31,
($ in thousands)	2024		2023
Deferred tax assets:
Net operating loss carryovers	$	95,131	$	84,651
Stock compensation and other		1,537		1,946
Change in fair value of warrant liabilities		59		59
Amortization of license		9,672		11,856
Lease liability		326		929
Accruals and reserves		1,922		1,841
Startup costs		4		5
Tax credits		19,046		18,189
174 Capitalization		24,437		28,800
Total deferred tax assets		152,134		148,276
Less: valuation allowance		(152,104)		(147,694)
Net deferred tax assets	$	30	$	582

Deferred tax liabilities:
Right of use asset		(30)		(582)
Total deferred tax assets, net	$	—	$	—